Image of Rachel Spruce

Dr Rachel Spruce

Industry Partnerships and Commercialisation Executive, Medicine

Rachel holds a PhD in Molecular Biology and Oncology and has over 10 years of experience working as an academic in a University setting. Rachel’s academic background is combined with formal training and experience in technology transfer to support the Faculty of Medicine to assess research discoveries for commercial potential and advance these technologies through to market adoption.

Rachel’s role is focused on supporting access to translational funds, collaboration with industry, intellectual property protection, marketing, licensing or spin out.

Rachel 's portfolio

Invariant Natural Killer T cell (iNKT cell) engagers

Invariant Natural Killer T cell (iNKT cell) engagers

, ,

An immunotherapy platform capable of enhancing the anti-tumour efficacy of invariant natural killer T cells (iNKT). Find out more

anti-TCRVbeta Chimeric Antigen Receptors (CARs)

anti-TCRVbeta Chimeric Antigen Receptors (CARs)

, ,

anti-TCRVbeta Chimeric Antigen Receptors which can target pathological T cells in a highly selective manner, leaving >90% of the patient's T cells and T cell-dependent immunity intact. Find out more

Gene expression signature to diagnose multiple infectious & inflammatory diseases in children

Gene expression signature to diagnose multiple infectious & inflammatory diseases in children

, ,

A gene expression signature capable of simultaneous diagnosis of multiple diseases in children. The technology can detect 18 different infectious and inflammatory diseases in children that present with similar symptoms. Find out more

Treatment of Tissue Fibrosis

Treatment of Tissue Fibrosis

, ,

Itaconate and itaconate analogues capable of inhibiting succinate dehydrogenase can be used to treat or prevent tissue fibrosis. Find out more

HKMT Inhibitors

HKMT Inhibitors

,

HKMTi-1-005 is a dual G9A/EZH2 histone methyltransferase which reactivates epigenetically repressed genes and inhibits tumour cell growth. Find out more

Machine learning tool stratifying early and late Alzheimer’s disease (ApV)

Machine learning tool stratifying early and late Alzheimer’s disease (ApV)

, ,

A tool for predicting Alzheimer’s Disease with greater accuracy than conventional methods. Find out more

Two-gene signature diagnostic test for differentiating between viral and bacterial infections in children

Two-gene signature diagnostic test for differentiating between viral and bacterial infections in children

,

A simple, whole blood 2-gene expression signature that distinguishes bacterial infection from both viral infection and childhood inflammatory diseases. Find out more

Octreotate Radioligand for Imaging Neuroendocrine Tumors

Octreotate Radioligand for Imaging Neuroendocrine Tumors

,

18F-FET-βAG-TOCA is a novel, ‘click’ 18F-labelled octreotate PET imaging radiopharmaceutical that detects tumour lesions in patients with neuroendocrine tumours (NETs). Find out more

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Sign up now
Loading...